These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2412008)

  • 1. Pathophysiological background for the use of calcium antagonists.
    Aoki K; Sato K
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S28-32. PubMed ID: 2412008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cardiovascular responses to norepinephrine and calcium antagonists in essential hypertension compared with normotension in humans.
    Aoki K; Sato K; Kawaguchi Y
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S182-6. PubMed ID: 2414585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nisoldipine. Central haemodynamics at rest and during exercise in essential hypertension: acute and chronic studies.
    Omvik P; Lund-Johansen P; Haugland H
    J Hypertens; 1988 Feb; 6(2):95-103. PubMed ID: 3351300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of calcium antagonists in the treatment of essential hypertension.
    Klein W; Brandt D; Vrecko K; Härringer M
    Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production by R-alpha-methylhistamine of a histamine H3 receptor-mediated decrease in basal vascular resistance in guinea-pigs.
    McLeod RL; Gertner SB; Hey JA
    Br J Pharmacol; 1993 Oct; 110(2):553-8. PubMed ID: 7902173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension.
    Omvik P; Lund-Johansen P
    Ann Clin Res; 1988; 20 Suppl 48():23-30. PubMed ID: 3250315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats.
    Aoki K; Kawaguchi Y; Sato K; Kondo S; Yamamoto M
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S298-302. PubMed ID: 6184557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Ca++-antagonists on systemic capacitance vessels and venous return curves of dogs--a study with mean circulatory pressure.
    Kotoo Y; Ito H; Sahashi T; Wada H; Takai K; Hirakawa S
    Jpn Circ J; 1988 Dec; 52(12):1395-407. PubMed ID: 3241321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of increased serum calcium with elevated blood pressure and vascular resistance during calcium infusion in normotensive man.
    Aoki K; Miyagawa K
    J Hypertens; 1990 Jun; 8(6):579-83. PubMed ID: 2165093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic response: decrease in cardiac output vs reduction in vascular resistance.
    Lund-Johansen P
    Hypertension; 1983; 5(5 Pt 2):III49-57. PubMed ID: 6629461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central hemodynamic effects at rest and during exercise of acute and chronic treatment with nisoldipine in essential hypertension.
    Omvik P; Lund-Johansen P; Haugland H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S182-4. PubMed ID: 2455128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the cardiovascular effects of trans-diclofurime with different types of calcium antagonists in conscious spontaneously hypertensive rats.
    Petty MA; Mir AK
    Br J Pharmacol; 1988 Aug; 94(4):1218-24. PubMed ID: 3207982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries.
    Dohi Y; Criscione L; Pfeiffer K; Lüscher TF
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):372-9. PubMed ID: 7528292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical model for dynamics of cardiovascular drug action: application to intravenous dihydropyridines in healthy volunteers.
    Francheteau P; Steimer JL; Merdjan H; Guerret M; Dubray C
    J Pharmacokinet Biopharm; 1993 Oct; 21(5):489-514. PubMed ID: 8145128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the sympathetic control of vascular resistance in ethanol-clonidine hemodynamic interaction in SHRs.
    El-Mas MM; Abdel-Rahman AA
    J Cardiovasc Pharmacol; 1999 Oct; 34(4):589-96. PubMed ID: 10511136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists in the therapy of hypertension].
    Heidland A; Heidbreder E; Hörl WH; Schäfer RM
    Klin Wochenschr; 1983 Jul; 61(13):633-40. PubMed ID: 6350692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.